Cogent Biosciences (COGT) Preferred Shares (2020 - 2026)

Cogent Biosciences (COGT) has 7 years of Preferred Shares data on file, last reported at $35.6 million in Q1 2026.

• On a quarterly basis, Preferred Shares fell 34.24% year-over-year to $35.6 million in Q1 2026; TTM through Mar 2026 was $35.6 million, a 34.24% decrease from a year earlier, with the FY2025 full-year figure at $53.8 million, changed 0.47% from the prior year.
• Preferred Shares for Q1 2026 stood at $35.6 million, down from $53.8 million in the prior quarter.
• Over the last five years, Preferred Shares for COGT reached as high as $162.1 million in Q1 2024 and fell as low as $35.6 million in Q1 2026.
• Historically, Preferred Shares has averaged $65.2 million across 5 years, with a median of $60.0 million in 2023.
• Across the five-year window, Preferred Shares soared 160.18% in 2024 and plunged 66.64% in 2025, its largest moves.
• Year by year, Preferred Shares stood at $65.8 million in 2022, then fell by 8.8% to $60.0 million in 2023, then decreased by 9.91% to $54.1 million in 2024, then retreated by 0.47% to $53.8 million in 2025, then plunged by 33.93% to $35.6 million in 2026.
• Per Business Quant data, the three most recent Preferred Shares figures were $35.6 million in Q1 2026, $53.8 million in Q4 2025, and $53.8 million in Q3 2025.